Chapter 5: Complementary & Alternative Therapies in Care

Central to the discussion is the regulatory framework established by the Dietary Supplement Health and Education Act of 1994, which significantly altered how the government oversees botanical products by categorizing them as dietary supplements rather than pharmaceuticals. This distinction means that while the Food and Drug Administration and Federal Trade Commission monitor labeling and advertising to prevent unsubstantiated curative claims, manufacturers are not required to provide pre-market proof of safety or efficacy. The text details various herbal preparations—including tinctures, infusions, and decoctions—and examines the therapeutic profiles and side effects of widely used botanicals such as Asian ginseng for vitality, garlic for cardiovascular health, and St. John’s wort for mood regulation. A major emphasis is placed on the physiological dangers of drug-herb interactions, particularly those involving the cytochrome P450 enzyme system, which can dangerously alter the metabolism of vital medications like anticoagulants, antidepressants, and protease inhibitors. From a clinical perspective, the nursing process is highlighted as a tool for ensuring patient safety through culturally sensitive and nonjudgmental assessments to uncover supplement use, which is frequently underreported by patients. Healthcare professionals are encouraged to educate patients on the risks of self-treating, the importance of brand consistency, and the critical need to discontinue herbal therapies at least two to three weeks prior to surgical procedures to avoid complications like excessive bleeding or adverse reactions to anesthesia. Ultimately, the material reinforces the concept that natural substances are not inherently safe and require informed clinical oversight to maintain health and wellness.